MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/02698811241309612

Медицинская библиотека · Journal of psychopharmacology (Oxford, England) · 2025

The efficacy of vortioxetine in the acute treatment of major depressive disorder: A systematic review and meta-analysis.

Berardelli Isabella, Rogante Elena, Formica Federico, Iannazzo Riccardo, Mammoliti Attilio Valerio, Riccioni Raffaele, Veizi Skender, McIntyre Roger S, Pompili Maurizio

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

BACKGROUND

Among the available pharmacological treatments for acute major depressive disorder (MDD), vortioxetine, a serotonin transporter inhibitor (SERT), has been widely used for its multimodal action on serotonin neurotransmission, which produces essential changes also on glutamate, gamma amino butyric acid (GABA), norepinephrine, acetylcholine, and dopamine.

AIM: This systematic review and meta-analysis aimed to evaluate the acute efficacy of vortioxetine across multiple dosing and to evaluate whether there is a dose-response effect and as well there is a dose-response issue with respect to side effects in acute depression.

METHODS

According to PRISMA guidelines, we systematically searched three major electronic databases (PubMed/MEDLINE, PsycINFO, and Cochrane Central Register of Controlled Trials) for Randomized Controlled Trial (RCT) studies published between January 2013 and April 2024. Twenty-four studies were included in the review and two meta-analyses were conducted to determine whether the mean Montgomery-Asberg Depression Rating Scale (MADRS) scale values in the placebo groups differ significantly from the mean MADRS scale values in the group receiving vortioxetine 10 mg or vortioxetine 20 mg.

RESULTS

Vortioxetine significantly improved acute depression severity, anxiety symptoms, and cognitive function, with high response and remission rates in acute MDD. It was also well tolerated with a relatively low occurrence of severe or serious treatment-emergent adverse events (TEAEs). Observing the results of the meta-analysis, the effect was significant for both vortioxetine 10 and 20 mg, with a greater effect size for vortioxetine 20 mg.

CONCLUSION

Vortioxetine should be considered efficacious as a first- and second-line therapy.

Для цитирования: Berardelli Isabella, Rogante Elena, Formica Federico, Iannazzo Riccardo, Mammoliti Attilio Valerio, Riccioni Raffaele, Veizi Skender, McIntyre Roger S, Pompili Maurizio. The efficacy of vortioxetine in the acute treatment of major depressive disorder: A systematic review and meta-analysis.. Journal of psychopharmacology (Oxford, England). 2025. DOI: 10.1177/02698811241309612.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.